Lauren A. Eberly, MD, MPH

Original Contribution

Identifying Racial, Ethnic, and Socioeconomic Inequities in the Use of Novel P2Y12 Inhibitors After Percutaneous Coronary Intervention

03/01/2022

Ashwin S. Nathan , MD;

Zhi Geng , MD, MPH;

Lauren A. Eberly , MD, MPH;

Nwamaka D. Eneanya , MD, MPH;

Jay S. Giri , MD, MPH;

Elias J. Dayoub , MD, MPP;

Daniel M. Kolansky , MD;

Sameed Ahmed M. Khatana , MD, MPH;

Sony Tuteja , PharmD, MS;

Alexander C. Fanaroff , MD, MHS;

Peter W. Groeneveld , MD, MS;

Taisei J. Kobayashi , MD;

Novel P2Y12 inhibitors prasugrel and ticagrelor were approved for patients with acute coronary syndrome (ACS) in 2009 and 2011, respectively. We assessed the association of racial, ethnic, and socioeconomic factors with initiation of and...

Novel P2Y12 inhibitors prasugrel...

03/01/2022

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Lauren A. Eberly, MD, MPH

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products